News about CV Outcomes, Inc.

CORC Collaborators in NHLBI Working Group Issue Outcomes Research Report

The National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease, co-chaired by Cardiovascular Outcomes Research Consortium members Harlan Krumholz and Eric Peterson and staffed by a number of other CORC colleagues, has just published its report in Circulation. The report is available for download here.

...Read more

Krumholz Publishes "The Expert Guide to Beating Heart Disease"

Harlan Krumholz MD SM, esteemed member of the Cardiovascular Outcomes
Research Consortium
and Professor of Medicine and Epidemiology and
Public Health at Yale University School of Medicine, has just published
a new patient-oriented book called The Expert Guide to Beating Heart Disease: What You Absolutely Must Know. “Harlan’s book beautifully describes the clinical applications of the sorts of outcomes research we do at CORC,” says John Spertus MD MPH, director of CORC. “His introduction to the Seattle Angina Questionnaire is particularly useful.”

...Read more

Peripheral Artery Questionnaire Released

CV Outcomes is pleased to provide licensing opportunities for the Peripheral Artery Questionnaire. The PAQ is a disease-specific health status measure for patients with peripheral arterial disease. Like the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire, the PAQ has been rigorously tested to demonstrate its validity, reliability and responsiveness. For a disease such as peripheral arterial disease, in which the primary goal of treatment is to improve patients’ symptoms, function and quality of life, it is hoped that the PAQ can serve as a primary endpoint in clinical trials, as a marker of severely affected patients requiring treatment and as a tool for improving the quality and follow-up of treated patients.

...Read more

Clinical Trials / Clinical Research Expo at Medinfo

The Epimetrics Group will showcase the CV Outcomes web site and its collaborative tools for academic research networks at the Clinical Trials / Clinical Research Expo at medInfo 2004. This session is sponsored by the AMIA Clinical Trials Working Group and will include a wide range of developers and users:

  • National Cancer Institute
  • University of Louisville
  • University of California, San Francisco
  • MedDak
  • City of Hope
  • Thomas Jefferson University
  • Intermountain Health Care
  • Merck & Company
  • Yale University
  • National Library of Medicine
  • The Epimetrics Group
  • The University of Washington
  • Johns Hopkins University
  • Datamedica

...Read more

Upgraded Server Now Functioning

After suffering a hard drive crash a week ago and hobbling along on a backup server in the interim, we’re now back in business with an upgraded server box. We think that all functions are running fine and that you should notice substantially improved performance. Please let us know if you encounter any problems, errors or other issues. Thanks!

Mid America Heart Institute Receives Multi-Million Dollar Research Grant

The National Institutes of Health has awarded Saint Luke’s Mid America Heart Institute in Kansas City and Washington University in St. Louis over $15 million in a Specialized Center for Clinically Oriented Research (SCCOR) grant to fund a five-year, multi-center study of patients recovering from heart attacks.

...Read more

New KCCQ Section

We’ve begun an informative series of articles about the Kansas City Cardiomyopathy Questionnaire here. Check this section out for information about the reliability, responsiveness and interpretability of the KCCQ, among other topics.

...Read more

Licensing Instruments at CV Outcomes

Through our online registration system, you can license and download our HRQOL instruments – currently the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire. You can also license and download tools that calculate the instruments’ scale scores from patient responses.

...Read more

Department of Defense Study

CV Outcomes has collaborated with Yale University to design and conduct a randomized controlled trial examining the impact of implementing decision support tools at two military treatment facilities.

...Read more

CORC and Wash U reach Reynolds Finals

An application to the Donald W.Reynolds Foundation to support a $24 million dollar Translational Research Grant from Washington University and the Mid America Heart Institute is selected as one of 4 finalist from an initial pool of 27 applicants from among the finest cardioavscular research insitutions in the country. Designed to advance the fight against cardiovascular disease and diabetes, the centerpiece of this innovative translational research effort is an ongoing post-MI registry by the Cardiovascular Outcomes Research Consortium (CORC).